SGMT·786700104·US·equity·Healthcare - Biotechnology-13D/G
SGMT (Sagimet Biosciences Inc. - Seri) is held by 52 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($7.5M), Woodline Partners LP ($5.9M), BAKER BROS. ADVISORS LP ($5.6M). Net institutional sentiment: Bullish.
See how SGMT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer